MNOV ▼ -6.4% - MediciNova, Inc.
$MNOV Announces Completion of Last Patient, Last Visit in the Double-Blind Portion of the Phase 2b/3 COMBAT-ALS Trial of MN-166 (Ibudilast) Topline data by EOY
24-SEP-2026 06:04 AM ET
Share this post
More filings for $MNOV
MNOV ▼ -11.8% - MediciNova, Inc.Oct 12, 2026MNOV ▲ +0.6% - MediciNova, Inc.Oct 6, 2026MNOV - MediciNova, Inc. - SEC Filing Update (29-SEP-2026) | ThinkSabio - Stocks SimplifiedSep 29, 2026MNOV ▼ -31.5% - MediciNova, Inc.Sep 28, 2026MNOV ▼ -6.4% - MediciNova, Inc.Sep 24, 2026
View full $MNOV filing history →💬 Comments
Loading comments…
Leave a comment